StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) stock

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-3.04%)

Close on Nov 17, 2026Market cap $1.60MP/E –Yield –

Vivos Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Vivos Therapeutics's total assets was $24.14M at Jun 30, 2026. For fiscal 2025 it was $25.15M, up 64.6% from the year before. The highest annual figure on record is $33.69M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.15M+64.6%
FY2024Dec 31, 2024$15.28M+42.4%
FY2023Dec 31, 2023$10.73M-21.8%
FY2022Dec 31, 2022$13.72M-59.3%
FY2021Dec 31, 2021$33.69M+33.0%
FY2020Dec 31, 2020$25.33M+235.4%
FY2019Dec 31, 2019$7.55M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$24.14M-7.3%
Q1 FY2026Mar 31, 2026$25.04M+122.0%
Q4 FY2025Dec 31, 2025$25.15M+64.6%
Q3 FY2025Sep 30, 2025$25.64M+67.1%
Q2 FY2025Jun 30, 2025$26.03M+64.3%
Q1 FY2025Mar 31, 2025$11.28M-4.4%
Q4 FY2024Dec 31, 2024$15.28M+42.4%
Q3 FY2024Sep 30, 2024$15.35M+48.8%
Q2 FY2024Jun 30, 2024$15.84M+15.2%
Q1 FY2024Mar 31, 2024$11.80M-31.0%
Q4 FY2023Dec 31, 2023$10.73M-21.8%
Q3 FY2023Sep 30, 2023$10.32M-43.9%
Q2 FY2023Jun 30, 2023$13.75M-43.6%
Q1 FY2023Mar 31, 2023$17.10M-42.1%
Q4 FY2022Dec 31, 2022$13.72M-59.3%
Q3 FY2022Sep 30, 2022$18.40M-55.1%
Q2 FY2022Jun 30, 2022$24.38M-47.2%
Q1 FY2022Mar 31, 2022$29.56M+34.6%
Q4 FY2021Dec 31, 2021$33.69M+33.0%
Q3 FY2021Sep 30, 2021$41.02M+443.3%
Q2 FY2021Jun 30, 2021$46.16M–
Q1 FY2021Mar 31, 2021$21.95M–
Q4 FY2020Dec 31, 2020$25.33M–
Q4 FY2019Dec 31, 2019$7.55M–

More Vivos Therapeutics figures

See a number that looks wrong?